Maravai LifeSciences (MRVI) Q2 2026 earnings call: revenue $51.4M, margin/EBITDA jump, guidance update and debt refi.
$MRVI
Price history, market instrument context, member research, and related headlines in one place.
MRVI key statistics
NasdaqGSUSD
52-week range
$2.5558%$9.42
Latest session $6.33–$6.67Maravai LifeSciences Holdings, Inc. (MRVI) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $6.55, up $0.02 (0.31%) from the previous close of $6.53. It has traded between $6.33 and $6.67 in the latest session. Over the past year it has ranged from $2.55 to $9.42, leaving it around the middle of its 52-week range (58%). Reported volume for the session was 2.7M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Maravai Lifesciences in focus: Can Q1 momentum hold in earnings? — See source for full details.
Loading $MRVI research…